Literature DB >> 31259036

G-Computation and Hierarchical Models for Estimating Multiple Causal Effects From Observational Disease Registries With Irregular Visits.

Zach Shahn1, Ying Li1, Zhaonan Sun1, Amrita Mohan2, Cristina Sampaio2, Jianying Hu1.   

Abstract

Huntington's Disease (HD) is a neurodegenerative disorder with serious motor, cognitive, and behavioral symptoms. Chorea, a motor symptom of HD characterized by abrupt involuntary movements, is typically treated with tetrabenazine or certain off-label antipsychotics. Clinical trial evidence about the impact of these drugs in the HD population is scant. However, multiple observational HD registries have recently been used with success to model HD progression1,2 and provide an opportunity to obtain effect estimates in the absence of clinical trials. We use a dataset integrated from four large-scale HD registries to generate evidence on the efficacy of chorea treatments for chorea as well as their impact on other aspects of HD progression. Clinical conclusions are meant only to illustrate our methodological approach. We employ parametric G-computation for causal inference to adjust for confounding and accommodate irregular visits and treatment patterns. We fit Bayesian hierarchical models to the results of multiple related analyses to share strength across studies and handle multiple comparisons concerns.

Entities:  

Year:  2019        PMID: 31259036      PMCID: PMC6568089     

Source DB:  PubMed          Journal:  AMIA Jt Summits Transl Sci Proc


  13 in total

1.  The Unified Medical Language System (UMLS): integrating biomedical terminology.

Authors:  Olivier Bodenreider
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Intervening on risk factors for coronary heart disease: an application of the parametric g-formula.

Authors:  Sarah L Taubman; James M Robins; Murray A Mittleman; Miguel A Hernán
Journal:  Int J Epidemiol       Date:  2009-04-23       Impact factor: 7.196

3.  A Data-Driven Method for Generating Robust Symptom Onset Indicators in Huntington's Disease Registry Data.

Authors:  Zhaonan Sun; Ying Li; Soumya Ghosh; Yu Cheng; Amrita Mohan; Cristina Sampaio; Jianying Hu
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

Review 4.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

5.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

6.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

Review 7.  The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation.

Authors:  Marina Papoutsi; Izelle Labuschagne; Sarah J Tabrizi; Julie C Stout
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

8.  Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY.

Authors:  Michael Orth; Olivia J Handley; Carsten Schwenke; Stephen B Dunnett; David Craufurd; Aileen K Ho; Edward Wild; Sarah J Tabrizi; G Bernhard Landwehrmeyer
Journal:  PLoS Curr       Date:  2010-09-28

Review 9.  Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.

Authors:  Emma M Coppen; Raymund A C Roos
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

10.  Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Authors:  J S Paulsen; D R Langbehn; J C Stout; E Aylward; C A Ross; M Nance; M Guttman; S Johnson; M MacDonald; L J Beglinger; K Duff; E Kayson; K Biglan; I Shoulson; D Oakes; M Hayden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12-20       Impact factor: 10.154

View more
  2 in total

1.  Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.

Authors:  Branduff McAllister; James F Gusella; G Bernhard Landwehrmeyer; Jong-Min Lee; Marcy E MacDonald; Michael Orth; Anne E Rosser; Nigel M Williams; Peter Holmans; Lesley Jones; Thomas H Massey
Journal:  Neurology       Date:  2021-03-25       Impact factor: 11.800

2.  Systematically exploring repurposing effects of antihypertensives.

Authors:  Zach Shahn; Phoebe Spear; Helen Lu; Sharon Jiang; Suki Zhang; Neil Deshmukh; Shenbo Xu; Kenney Ng; Roy Welsch; Stan Finkelstein
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-06-21       Impact factor: 2.732

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.